Web7 dec. 2024 · PURPOSE Palbociclib is a cyclin-dependent kinase 4 and 6 inhibitor approved for advanced breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine therapy for hormone receptor–positive breast cancer has not been confirmed. PATIENTS AND METHODS In the prospective, randomized, phase III PALLAS trial, … Web18 jan. 2024 · Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer. Immunomedics’ corporate objective is to become a...
SEC Actions This Week: Insider Trading? What Insider Trading?
Web2 dec. 2024 · Usama Malik, then an executive for Immunomedics, tipped his former partner, Lauren S. Wood, that the company’s breast cancer drug had proven effective in … Web2 dec. 2024 · The ex-chief financial officer Usama Malik, 47, and Lauren S. Wood, 33, ex-head of corporate communications of the former Immunomedics were arrested … bishop hr
Former biopharmaceutical corporate comms chief pleads guilty to …
Web2 dec. 2024 · Wood, who had left the company four months earlier but lived with Malik, allegedly bought about 7,000 Immunomedics shares that night for $64,400, and sold … Web10 mei 2024 · A former chief financial officer of a New Jersey biotechnology company has been indicted for insider trading after allegedly giving his girlfriend nonpublic information … WebImmunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2024, the company was acquired by … darkmantle armor wow